Strengthening management of sickle cell disease in Bangui
— The Central African Republic —
In 2011, pursuing the work already begun in Mali, Fondation Pierre Fabre became involved in the battle against sickle cell disease in the CAR. This country has a record rate of this illness, affecting 2% of infants, but also has very poor overall state of affairs in human health: the life expectancy, just 45 years, is ten years below the African average.
The Foundation focused its attention on the Bangui paediatric complex, an establishment created in 1988 providing care to those ages 0 to18 and the country’s sole modern paediatric healthcare facility. With the Foundation’s support, it would receive new equipment and supplies to improve patient reception, provide staff with increased knowledge of sickle cell disease (through cross-training with Bamako and Kinshasa), set up screening campaigns and raise public awareness of the disease.
Combating Sickle cell disease
Type of involvement
Distributor and operator
- Supply of medical equipment and consumables
- Training funding and organisation
Unfortunately, in 2013, when the Foundation had already provided the planned materials and completed its contribution to healthcare worker training, civil war broke out. The humanitarian emergency gradually took precedence over the targeted programmes and the Foundation had to accept the necessity of suspending its interventions there. It hopes to resume activities as soon as possible.
- Complexe pédiatrique de Bangui
Support for the Sickle Cell Research and Treatment Centre (CRTD)
The Fondation Pierre Fabre has been supporting the Bangui Sickle Cell Research and Treatment Centre (CRTD) since 2019. The CRTD is the country’s only referral institution and receives financial support for training and purchasing medicines and equipment.19/10/2021
Supporting the fight against sickle cell disease in Sub-Saharan Africa
This multi-country project must address the major challenge of reducing morbidity and mortality linked to sickle cell disease by acting on several levels: Detect, treat, train, raise awareness and support public authorities30/03/2022
Follow our actions
Haemophilia and sickle cell disease: Increasing our impact together in Guinea
A new partnership agreement has been signed between the Novo Nordisk Haemophilia Foundation (NNHF) and the Fondation Pierre Fabre to jointly improve awareness, diagnosis, care, and advocacy for blood disorders in Guinea.